ImmunoBiome
1 known investors
Find your way into ImmunoBiome
ImmunoBiome develops microbiome-based therapeutics targeting intractable immune diseases such as cancer and autoimmune disorders, drawing on immunology, bioinformatics, and microbiome research. The company operates in the biotech and drug development space.
Investors · 1
In the news
Frequently asked questions
- What does ImmunoBiome do?
- ImmunoBiome develops microbiome-based therapeutics targeting intractable immune diseases such as cancer and autoimmune disorders, drawing on immunology, bioinformatics, and microbiome research. The company operates in the biotech and drug development space.
- Who are ImmunoBiome's investors?
- ImmunoBiome's investors include Aju IB Invesment Corporation.